Giant cell arteritis with or without aortitis at diagnosis. A retrospective study of 22 patients with longterm followup

Journal of Rheumatology

Volumn 39, Issue 11, 2012, Pages 2157-2162

  Espitia, Olivier ^a   Néel, Antoine ^a   Leux, Christophe ^a   Connault, Jérome ^a   Espitia Thibault, Alexandra ^a   Ponge, Thierry ^a   Dupas, Benoit ^a   Barrier, Jacques H ^a   Hamidou, Mohamed A ^a   Agard, Christian ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Aortic aneurysm; Aortitis; Giant cell arteritis; Prognosis

Indexed keywords

METHYLPREDNISOLONE; PREDNISONE; STEROID;

AGED; AORTA ANEURYSM; AORTITIS; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; GIANT CELL ARTERITIS; HUMAN; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; RELAPSE; RETROSPECTIVE STUDY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STEROID THERAPY;

AGED; AGED, 80 AND OVER; AORTIC ANEURYSM; AORTITIS; COHORT STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; GIANT CELL ARTERITIS; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84868376277     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120511     Document Type: Article

References (35)

1. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008;372:234-45.
2. Nuenninghoff DM, Hunder GG, Christianson TJH, McClelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: A population-based study over 50 years. Arthritis Rheum 2003;48:3522-31.
3. García-Martínez A, Hernández-Rodríguez J, Arguis P, Paredes P, Segarra M, Lozano E, et al. Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: A cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum 2008;59:422-30.
4. Agard C, Ponge T, Fradet G, Baron O, Sagan C, Masseau A, et al. Giant cell arteritis presenting with aortic dissection: Two cases and review of the literature. Scand J Rheumatol 2006;35:233-6.
5. Nuenninghoff DM, Hunder GG, Christianson TJH, McClelland RL, Matteson EL. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003;48:3532-7.
6. Evans JM, Bowles CA, Bjornsson J, Mullany CJ, Hunder GG. Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases. Arthritis Rheum 1994;37:1539-47.
7. Klein RG, Hunder GG, Stanson AW, Sheps SG. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 1975;83:806-12.
8. Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 1995;122:502-7.
9. Gonzalez-Gay MA, Garcia-Porrua C, Piñeiro A, Pego-Reigosa R, Llorca J, Hunder GG. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: A population-based study. Medicine 2004;83:335-41.
10. Marie I, Proux A, Duhaut P, Primard E, Lahaxe L, Girszyn N, et al. Long-term follow-up of aortic involvement in giant cell arteritis: a series of 48 patients. Medicine 2009;88:182-92.
11. Martínez-Valle F, Solans-Laqué R, Bosch-Gil J, Vilardell-Tarrés M. Aortic involvement in giant cell arteritis. Autoimmun Rev 2010;9:521-4.
12. Bossert M, Prati C, Balblanc J-C, Lohse A, Wendling D. Aortic involvement in giant cell arteritis: Current data. Joint Bone Spine 2011;78:246-51.
13. Agard C, Barrier J-H, Dupas B, Ponge T, Hahr A, Fradet G, et al. Aortic involvement in recent-onset giant cell (temporal) arteritis: A case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum 2008;59:670-6.
14. Prieto-González S, Arguis P, García-Martínez A, Espigol-Frigole G, Tavera-Bahillo I, Butjosa M, et al. Large vessel involvement in biopsy-proven giant cell arteritis: Prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis 2012;71:1170-6.
15. Blockmans D. PET in vasculitis. Ann NY Acad Sci 2011; 1228:64-70.
16. Blockmans D, de Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: A prospective study of 35 patients. Arthritis Rheum 2006;55:131-7.
17. Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med 1996;100:193-6.
18. Nesher G, Sonnenblick M, Friedlander Y. Analysis of steroid related complications and mortality in temporal arteritis: A 15-year survey of 43 patients. J Rheumatol 1994;21:1283-6.
19. Ninan J, Nguyen A-M, Cole A, Rischmueller M, Dodd T, Roberts-Thomson P, et al. Mortality in patients with biopsy-proven giant cell arteritis: a South Australian population-based study. J Rheumatol 2011;38:2215-7.
20. Nordborg E, Bengtsson BA. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. BMJ 1989;299:549-50.
21. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: A 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 1978;88:162-7.
22. Blockmans D, Coudyzer W, Vanderschueren S, Stroobants S, Loeckx D, Heye S, et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology 2008;47:1179-84.
23. Both M, Ahmadi-Simab K, Reuter M, Dourvos O, Fritzer E, Ullrich S, et al. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis. Ann Rheum Dis 2008;67:1030-3.
24. Cimmino MA, Zampogna G, Parodi M. Is FDG-PET useful in the evaluation of steroid-resistant PMR patients? Rheumatology 2008;47:926-7.
25. Agard C, Said L, Ponge T, Connault J, Masseau A, Pistorius MA, et al. Abdominal aortic involvement in active giant cell (temporal) arteritis: A study of 20 patients by Doppler ultrasonography and computed tomographic angiography [French]. Presse Med 2009;38:11-9.
26. Brodmann M, Lipp RW, Passath A, Seinost G, Pabst E, Pilger E. The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology 2004;43:241-2.
27. Assie C, Janvresse A, Plissonnier D, Levesque H, Marie I. Long-term follow-up of upper and lower extremity vasculitis related to giant cell arteritis: A series of 36 patients. Medicine 2011;90:40-51.
28. Schmidt WA, Moll A, Seifert A, Schicke B, Gromnica-Ihle E, Krause A. Prognosis of large-vessel giant cell arteritis. Rheumatology 2008;47:1406-8.
29. Uddhammar A, Eriksson A-L, Nyström L, Stenling R, Rantapää-Dahlqvist S. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol 2002;29:737-42.
30. Ray JG, Mamdani MM, Geerts WH. Giant cell arteritis and cardiovascular disease in older adults. Heart 2005;91:324-8.
31. Mahr AD, Jover JA, Spiera RF, Hernandez-Garcia C, Fernandez-Gutierrez B, Lavalley MP, et al. Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta-analysis. Arthritis Rheum 2007;56:2789-97.
32. Martínez-Taboada VM, Rodríguez-Valverde V, Carreño L, Lopez-Longo J, Figueroa M, Belzunequi J, et al. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects. Ann Rheum Dis 2008;67:625-30.
33. Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, et al. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: A randomized trial. Ann Intern Med 2007;146:621-30.
34. De Silva M, Hazleman BL. Azathioprine in giant cell arteritis/polymyalgia rheumatica: A double-blind study. Ann Rheum Dis 1986;45:136-8.
35. Martinez-Lado L, Calviño-Díaz C, Piñeiro A, Dierssen T, Vazquez-Rodriquez TR, Miranda-Filloy JA, et al. Relapses and recurrences in giant cell arteritis: A population-based study of patients with biopsy-proven disease from northwestern Spain. Medicine 2011;90:186-93.